Recent 8-K filings for BFRG
Highest-materiality recent filing
BullFrog AI receives Nasdaq delisting notice for failing equity requirement; will request hearing
- Nasdaq notified BullFrog AI on Feb 19, 2026 that it failed to meet extension terms for the $2.5M stockholders' equity requirement.
- Securities are subject to delisting unless company timely requests a hearing before the Nasdaq Hearings Panel.
-
BullFrog AI regains Nasdaq minimum stockholders' equity compliance
Received Nasdaq notice on April 21, 2026 confirming compliance with $2.5M minimum equity requirement.
-
BullFrog AI secures first commercial agreement with top 5 pharma; runway into late 2027
First commercial feasibility agreement with a top 5 global pharma for bfLEAP platform in MDD (market >$8B).
-
BullFrog AI raises $3.45M, now believes it meets Nasdaq equity requirement; avoids delisting
Raised aggregate net proceeds of at least $3.45M from ATM sales and equity line of credit facility.
-
BullFrog AI signs feasibility agreement with top-5 pharma for MDD target discovery
Agreement with top-5 global pharma (by 2025 revenue) for bfLEAP platform to identify novel drug targets in major depressive disorder (MDD).
-
BullFrog AI receives Nasdaq delisting notice for failing equity requirement; will request hearing
Nasdaq notified BullFrog AI on Feb 19, 2026 that it failed to meet extension terms for the $2.5M stockholders' equity requirement.
-
BullFrog AI receives Nasdaq deficiency notice for bid price below $1.00
Nasdaq notified BullFrog AI on Feb 10, 2026 that common stock bid closed below $1.00 for 30 consecutive business days.
-
BullFrog AI details 2025 progress, pharma partnerships, and 2026 catalysts
Annual cash burn ~$6.2M; $10M equity line and ATM provide financing flexibility.
-
BullFrog AI stockholders approve reverse stock split and 750,000 share increase to equity plan
Approved reverse stock split at ratio between 1:2 and 1:15, with Board discretion on final ratio.
-
BullFrog AI receives Nasdaq extension until Feb 17, 2026 to meet equity requirement
Nasdaq granted BullFrog AI an extension until Feb 17, 2026 to regain compliance with $2.5M minimum stockholders' equity requirement.
-
BullFrog AI secures $10M equity line with Lincoln Park Capital
Entered purchase agreement with Lincoln Park Capital Fund for up to $10M of common stock over 36 months.
-
Stockholders' equity of $2,188,110 as of June 30, 2025 falls below Nasdaq's $2.5M minimum requirement.
-
Bullfrog AI enters collaboration with Eleison to optimize Phase 3 pancreatic cancer trial
Collaboration announced Feb 27, 2025; Bullfrog AI to apply bfLEAP platform to Eleison's glufosfamide Phase 3 trial.
Materiality & sentiment trend
Max materiality 0.80 · Median 0.62 · Most common event other_material